The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early intervention.
Today, we're diving deep into a crucial aspect of preventive healthcare: the annual wellness visit. Our guest is Christopher Wheelock, MD, a clinical transformation physician executive at Highmark Health, responsible for developing payer and provider collaborations to move toward value-based care. In the past, he was heavily involved with developing the workflow, patient scripting and templating for the annual wellness visit when CMS first established it in 2011 as part of the Affordable Care Act.
In today’s episode, Wheelock sheds light on the various elements of the annual wellness visit, including self-assessments of psychosocial issues and screenings for conditions like dementia and incontinence. He also explains the expansion of services in 2025 for Medicare beneficiaries.
We also explore the intricacies of coding and billing for these visits, especially if they go beyond the scope of the annual wellness visit; the value they bring to patients, providers, and payers; and the critical role of effective communication and preparation to maximize the benefit of the annual wellness visit.
Listen above or on one of these podcast services:
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More